An Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin After Single and Multiple Doses Administered Orally in Healthy Volunteers
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Finafloxacin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Adverse reactions
- 02 Aug 2013 New trial record